1. Structure-Based Design of Novel G-Protein-Coupled Receptor TAAR1 Agonists as Potential Antipsychotic Drug Candidates
- Author
-
Zhou, Zhenzhen, Zhang, Weifeng, Zhao, Fabao, Sun, Yanying, Wang, Na, Cheng, Jie, Zhan, Peng, Yang, Fan, Sun, Jin-Peng, Liu, Xinyong, and Kang, Dongwei
- Abstract
The existing available antipsychotics have failed to manage the cognitive impairment of schizophrenia and induced a number of seriously undesirable effects. Trace amine-associated receptor 1 (TAAR1) has emerged as an ideal target for the design of antischizophrenia drugs, with the ability to mediate multiple psychological functions by sensing endogenous amine-containing metabolites without the side effects of catalepsy. In this work, a series of novel TAAR1 agonists were designed based on the structural analysis of the TAAR1 activation pocket. Among them, 6edisplayed a potent TAAR1-Gs/Gqdual-pathway activation property, being different from that of the clinical drug candidate SEP-363856 with only TAAR1-Gspathway activation. In rodent models, 6esignificantly alleviated MK-801-induced schizophrenia-like cognitive phenotypes without inducing catalepsy. Furthermore, 6e·HClexhibited favorable pharmacokinetic (T1/2= 2.31 h, F= 39%) and safety properties. All these demonstrated that 6e·HClmay be used as a novel drug candidate for schizophrenia treatment.
- Published
- 2024
- Full Text
- View/download PDF